Novasep Inks Partnership Agreements with Two Japan-Based Companies
The supplier will add Allied Laboratories and AR Brown to its list of global partners.
Novasep announced on June 8, 2015 that it is entering into partnerships with two separate companies based in Japan: Allied Laboratories and AR Brown. Allied Laboratories will provide business development and technical services for clients using Novasep’s chromatography and bioprocess equipment in Japan, while AR Brown will represent Novasep’s contract manufacturing organization services in this market.
Novasep hopes that the partnerships will allow expanded local support for its clients in the region. The company set up its Asia process development and engineering center in Shanghai, China, in 2012, and expanded its presence in South East Asia with the opening of an office in Bangkok, Thailand in December 2014.
Source: Novasep
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
